Get started
Author

Michela Barca

Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
2016 · Grazia Palomba, Valentina Doneddu, et al. · Journal of Translational Medicine · 64
PDF
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
2016 · Grazia Palomba, Antonio Cossu, et al. · Oncology Letters · 10
PDF
Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response (<pCR) After Primary Chemotherapy
2009 · Maria Teresa Ionta, Francesco Atzori, et al. · The Oncologist · 4
PDF
Prolonged disease stability with trabectedin in two monorenal patients with retroperitoneal sarcoma.
2014 · Francesca Bruder, Daniela Massa, et al. · PubMed · 1
CREAM study: Clinical correlation between immunotherapy-RElated clinical outcome and intestinal microbiote in metastatic patients.
2018 · Laura Orgiano, Alessio Cubeddu, et al. · Journal of Clinical Oncology
MOESM1 of Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
2016 · Palomba, Grazia, Doneddu, Valentina, et al. · Figshare
Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status
2015 · G. Palomba, A. Cossu, et al. · Annals of Oncology
PDF
Estudo longitudinal da funcao tireoidea , avaliacao ultra-sonografica e auto-imunidade hormonal em tireoidite pos-parto
1996 · Michela Barca, Eduardo Tomimori, et al. · Arquivos Brasileiros de Endocrinologia & Metabologia
Works count: 10
Citation count: 79
H-index: 3
I10-index: 2
Year
Topic
Type